Marton Laurence, a director at RenovoRx, Inc. ($RNXT), made one open market purchase of common shares in the last 365 days, totaling $10,218.40. His most recent buy occurred on April 8, 2025. This ranks him 4,253rd among nearly 5,000 individual insiders by purchase amount, well below the average of about $1.5 million across roughly 3.3 transactions per insider. Laurence reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 20, 2026 | RenovoRx, Inc. | $RNXT | Marton Laurence | Director | P | Common Stock | 9720 | $0.00 | 9,720.0000 | 36,649,916 | 9999.99% | 0.03% |
| March 20, 2026 | RenovoRx, Inc. | $RNXT | Marton Laurence | Director | P | Warrants | 4860 | $0.00 | 4,860.0000 | 36,649,916 | 9999.99% | 0.01% |
| Oct. 1, 2025 | RenovoRx, Inc. | $RNXT | Marton Laurence | Director | A | Stock Options (right to buy) | 47640 | $0.00 | 47,640.0000 | 36,546,752 | 9999.99% | 0.13% |
| May 2, 2025 | RenovoRx, Inc. | $RNXT | Marton Laurence | Director | M | Common Stock | 20480 | $0.15 | 66,164.0000 | 36,546,752 | 44.83% | 0.06% |
| May 2, 2025 | RenovoRx, Inc. | $RNXT | Marton Laurence | Director | M | Stock Option (right to buy) | 20480 | $0.00 | 0.0000 | 36,546,752 | 100.00% | 0.06% |
| April 8, 2025 | RenovoRx, Inc. | $RNXT | Marton Laurence | Director | P | Common Stock | 12050 | $0.85 | 45,684.0000 | 36,546,752 | 35.83% | 0.03% |
| Oct. 1, 2024 | RenovoRx, Inc. | $RNXT | Marton Laurence | Director | A | Stock Options (right to buy) | 25099 | $0.00 | 25,099.0000 | 0 | 9999.99% | 0.00% |
| Jan. 26, 2024 | RenovoRx, Inc. | $RNXT | Marton Laurence | Director | P | Warrants | 8196 | $0.00 | 8,196.0000 | 0 | 9999.99% | 0.00% |
| Jan. 26, 2024 | RenovoRx, Inc. | $RNXT | Marton Laurence | Director | P | Common Stock | 8196 | $0.00 | 33,634.0000 | 0 | 32.22% | 0.00% |